High concentration vitamin C drip

Today, a patient attending a high-concentration vitamin C drip in the typhoon was able to come.
Currently, during chemotherapy treatment for malignant tumors, the 1 chemotherapy had almost no side effects and I was pleased that I was able to receive chemotherapy very easily. Evidence is coming out one after another, but it seems that it will take time to disseminate because there are pharmaceutical manufacturers and insurance medical barriers in Japan. It has been realized that the combination therapy with energy really reduces the pain and greatly reduces the pain of cancer patients. (1) Scientists from the National Institutes of Health (NIH), National Cancer Center (NCI), and Food and Drug Administration (FDA) in 2005 found basic research papers that high-concentration vitamin C infusion therapy is useful for cancer Was published in the bulletin of the American Academy of Sciences and made an impact throughout the United States.
http://www.pnas.org/cgi/content/full/102/38/13604

(2) Researchers from the National Institutes of Health (NIH), National Cancer Center (NCI), and universities in 2006 in 3 cases where high-concentration vitamin C infusion therapy was clearly effective (kidney cancer, bladder cancer) , Malignant lymphoma) was compiled into a paper on the basis of NIH case reports.
http://www.cmaj.ca/cgi/content/full/174/7/937

(3) Two cases in which combined use of anticancer drugs and high-concentration vitamin C infusion therapy were effective for ovarian cancer (Stage IIIc) were published in the American Nutrition Society magazine by the University of Kansas Medical Center in 2003.
In both 2 cases, high-concentration vitamin C infusion therapy alone is good after anticancer drug administration.
http://www.jacn.org/cgi/content/abstract/22/2/118?ijkey=15532064060606a4bf7f2c91cb079c9dde36bb77&keytype2=tf_ipsecsha

(4) The University of Kansas is currently conducting clinical trials of high-concentration vitamin C infusion therapy for ovarian cancer, uterine body cancer, and cervical cancer with the approval of the National Institutes of Health (NIH) (NCT00284427).
http://www.clinicaltrials.gov/ct/show/NCT00284427